AbbVie Inc (NYSE:ABBV)

Monday’s trading has closed, but ABBV is being traded in the after-hours session. After-Hours quote »
69.34
Delayed Data
As of 4:00pm ET
 +1.26 / +1.85%
Today’s Change
51.37
Today|||52-Week Range
71.60
+5.96%
Year-to-Date
Benzinga's M&A Chatter for Monday July 27, 2015
7:58pm / Benzinga
Shire still on the hunt for acquisitions
Jul 23 / FT.com
Allergan signals appetite for new mega deal after $41bn disposal
4:17pm / FT.com
Celgene Rolling Along (but You Already Knew That)
Jul 23 / MotleyFool.com
4 Stocks to Fight the Virus on World Hepatitis Day - Analyst Blog
2:38pm / Zacks.com
The Zacks Analyst Blog Highlights: Amgen, Exelixis, Regeneron, Five Prime Therapeutic...
Jul 23 / Zacks.com
Gilead Can Soothe Biotech Investor Fears with Great 2Q Earnings
12:44pm / TheStreet.com
Biotech Stock Roundup: Amgen PCSK9 Inhibitor First to Gain Approval, Exelixis Up on P...
Jul 22 / Zacks.com
Company News for July 27, 2015 - Corporate Summary
10:47am / Zacks.com
Zacks Industry Outlook Highlights: AbbVie, Allergan, Pfizer, Juno and Johnson & Johns...
Jul 22 / Zacks.com
Watch Out: Barbarians At The Gate For AbbVie (ABBV)
10:00am / TheStreet.com
2015bs Top 6 Big Pharma Headlines Thus Far
Jul 22 / MotleyFool.com
Allergan sells generic drugs unit to Teva for $40bn
6:18am / FT.com
Pharma Stock Outlook - July 2015 - Zacks Analyst Interviews
Jul 21 / Zacks.com
Biotech high flyers face gravity test
4:32am / FT.com
Pharma Stock Outlook - July 2015 - Industry Outlook
Jul 21 / Zacks.com
AbbVie (ABBV) Earnings Report: Q2 2015 Conference Call Transcript
Jul 24 / TheStreet.com
New Lifetime High For AbbVie (ABBV)
Jul 21 / TheStreet.com
AbbVie's Investments Begin Kicking In
Jul 24 / MotleyFool.com
AbbVie Neurodegenerative Disorder Drug Gets Orphan Status - Analyst Blog
Jul 20 / Zacks.com
AbbVie (ABBV) Stock Sliding on Earnings Miss
Jul 24 / TheStreet.com
3 Health Care ETFs Leading the Sector Higher - ETF News And Commentary
Jul 16 / Zacks.com
AbbVie Tops Earnings, Misses on Revenues, Maintains View - Analyst Blog
Jul 24 / Zacks.com
Acquisitive Celgene shuns usual biotech growth model
Jul 16 / FT.com
AbbVie (ABBV) Tops 2Q Earnings but Misses Revenues - Tale of the Tape
Jul 24 / Zacks.com
4 Healthcare ETFs to Buy as JNJ Beats Estimates - ETF News And Commentary
Jul 15 / Zacks.com
Early Morning Activity Shows AbbVie (ABBV) Down
Jul 24 / TheStreet.com
Biotech boon as Celgene agrees $7.2bn Receptos deal
Jul 14 / FT.com
July 24 Premarket Briefing: 10 Things You Should Know
Jul 24 / TheStreet.com
Johnson & Johnson sales hit by 'biosimilar' competition
Jul 14 / FT.com
American Airlines Earnings and New Home Sales Will Wrap up Busy Week
Jul 23 / TheStreet.com
Midyear Report Card: Grading My Biotech Predictions for 2015
Jul 14 / MotleyFool.com
Will AbbVie (ABBV) Surprise on Earnings Again in Q2? - Analyst Blog
Jul 23 / Zacks.com
 

To view my watchlist

Not a member yet?

Sign up now for a free account